SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ALKERMES
(NQNM:ALKS Last Sale: 13.74 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ALKS : $13.74)
$2,167,999 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today

64 Sidney Street Research Report Earnings Snapshot - Last 10/29/18
Cambridge, MA 02139 Fact Sheet
Phone: (617) 494-0171 Financial Statements
Fax: (617) 494-9263 Peer Comparison
Annual Reports

Richard F. Pops, CEO, David A. Broecker, Pres./COO, James M. Frates, CFO
Develops products based on their drug delivery technologies.
Historical Charts    Technical Analysis
No Historical Data available for ALKS

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ALKS $13.74 $13.74 0 .0 $13.12 $13.76 1,383,439 $13.12 $13.76 157,787,433
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
12-MAY-00 ALKS Split 2 for 1

A596
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex